Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T₁/T₂ Dual-Contrast Magnetic Resonance Imaging

References

• Smith BR, Gambhir SS. Nanomaterials for in vivo imaging. Chem Rev. 2017;117(3):901–986. doi:10.1021/acs.chemrev.6b0007328045253
   PubMed Web of Science ®Google Scholar
• Ni D, Bu W, Ehlerding EB, et al. Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents. Chem Soc Rev. 2017;46(23):7438–7468. doi:10.1039/c7cs00316a29071327
   PubMedGoogle Scholar
• Weissleder R. Molecular imaging in cancer. Science. 2006;312:1168–1171.16728630
   PubMed Web of Science ®Google Scholar
• Weissleder R. Molecular imaging: exploring the next frontier. Radiology. 1999;212(3):609–614.10478223
   PubMed Web of Science ®Google Scholar
• Herschman HR. Molecular imaging: looking at problems, seeing solutions. Science. 2003;302(5645):605–608.14576425
   PubMed Web of Science ®Google Scholar
• Louie AY, Hüber MM, Ahrens ET, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol. 2000;18:321.10700150
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Cao J, et al. Functional investigations on embryonic stem cells labeled with clinically translatable iron oxide nanoparticles. Nanoscale. 2014;6(15):9025–9033.24969040
   PubMed Web of Science ®Google Scholar
• Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7(7):591–607.18591980
   PubMed Web of Science ®Google Scholar
• Yang Z, Ren J, Ye Z, et al. Bio-inspired synthesis of PEGylated polypyrrole@polydopamine nanocomposite as theranostic agent for t1-weighted MR imaging guided photothermal therapy. J Mater Chem B. 2017;5:1108–1116.
   PubMed Web of Science ®Google Scholar
• Zhang F, Ni Q, Jacobson O, et al. Polymeric nanoparticles with a glutathione-sensitive heterodimeric multifunctional prodrug for in vivo drug monitoring and synergistic cancer therapy. Angew Chem Int Ed Engl. 2018;57(24):7066–7070. doi:10.1002/anie.20180198429624828
   PubMedGoogle Scholar
• Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21(21):2133–2148. doi:10.1002/adma.v21:21
   Web of Science ®Google Scholar
• Zhang H, Li L, Liu XL, et al. Ultrasmall ferrite nanoparticles synthesized via dynamic simultaneous thermal decomposition for high-performance and multifunctional T1 magnetic resonance imaging contrast agent. ACS Nano. 2017;11(4):3614–3631. doi:10.1021/acsnano.6b0768428371584
   PubMed Web of Science ®Google Scholar
• Jang JT, Nah H, Lee JH, et al. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. Angew Chem Int Ed Engl. 2009;48(7):1234–1238. doi:10.1002/anie.20080514919137514
   PubMedGoogle Scholar
• Shin T-H, Choi J-S, Yun S, et al. T1 and T2 dual-mode MRI contrast agent for enhancing accuracy by engineered nanomaterials. ACS Nano. 2014;8:3393–3401. doi:10.1021/nn405977t24673493
   PubMedGoogle Scholar
• Kim BH, Lee N, Kim H, et al. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. J Am Chem Soc. 2011;133(32):12624–12631. doi:10.1021/ja203340u21744804
   PubMed Web of Science ®Google Scholar
• Zhou Z, Huang D, Bao J, et al. A synergistically enhanced T1-T2 dual-modal contrast agent. Adv Mater. 2012;24(46):6223–6228. doi:10.1002/adma.20120316922972529
   PubMed Web of Science ®Google Scholar
• Li J, You J, Wu C, et al. T1-T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents. Int J Nanomedicine. 2018;13:4607–4625. doi:10.2147/IJN.S16866030127609
   PubMed Web of Science ®Google Scholar
• Im GH, Kim SM, Lee DG, et al. Fe3O4/MnO hybrid nanocrystals as a dual contrast agent for both T1- and T2-weighted liver MRI. Biomaterials. 2013;34(8):2069–2076. doi:10.1016/j.biomaterials.2012.11.05423246062
   PubMedGoogle Scholar
• Tegafaw T, Xu W, Ahmad MW, et al. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application. Nanotechnology. 2015;26(36):365102. doi:10.1088/0957-4484/26/36/36510226291827
   PubMedGoogle Scholar
• Yang M, Gao L, Liu K, et al. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent. Talanta. 2015;131:661–665. doi:10.1016/j.talanta.2014.08.04225281156
   PubMedGoogle Scholar
• Sun X, Du R, Zhang L, et al. A pH-responsive yolk-like nanoplatform for tumor targeted dual-mode magnetic resonance imaging and chemotherapy. ACS Nano. 2017;11(7):7049–7059. doi:10.1021/acsnano.7b0267528665575
   PubMedGoogle Scholar
• Cabrera-Garcia A, Checa-Chavarria E, Pacheco-Torres J, et al. Engineered contrast agents in a single structure for T1-T2 dual magnetic resonance imaging. Nanoscale. 2018;10(14):6349–6360. doi:10.1039/C7NR07948F29560985
   PubMedGoogle Scholar
• Gong M, Yang H, Zhang S, et al. Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles. Int J Nanomedicine. 2016;11:4051–4063.27578974
   PubMed Web of Science ®Google Scholar
• Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev. 2012;41(7):2575–2589.22138852
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang X, Skallberg A, et al. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging. Nanoscale. 2014;6(5):2953–2963.24480995
   PubMed Web of Science ®Google Scholar
• Pellico J, Ruiz-Cabello J, Fernandez-Barahona I, et al. One-step fast synthesis of nanoparticles for MRI: coating chemistry as the key variable determining positive or negative contrast. Langmuir. 2017;33(39):10239–10247.28882034
   PubMed Web of Science ®Google Scholar
• Li Z, Wang SX, Sun Q, et al. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging. Adv Healthc Mater. 2013;2(7):958–964.23322490
   PubMed Web of Science ®Google Scholar
• Zhang M, Cao Y, Wang L, et al. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy. ACS Appl Mater Interfaces. 2015;7(8):4650–4658.25672225
   PubMed Web of Science ®Google Scholar
• Lee JH, Huh YM, Jun YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13(1):95–99.17187073
   PubMed Web of Science ®Google Scholar
• Tong S, Hou S, Zheng Z, et al. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett. 2010;10(11):4607–4613.20939602
   PubMed Web of Science ®Google Scholar
• LaConte LE, Nitin N, Zurkiya O, et al. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity. J Magn Reson Imaging. 2007;26(6):1634–1641.17968941
   PubMed Web of Science ®Google Scholar
• Lu J, Ma S, Sun J, et al. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials. 2009;30(15):2919–2928.19230966
   PubMed Web of Science ®Google Scholar
• RB LAUFFER. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging theory and design. Chem Rev. 1987;87:901–927.
   Web of Science ®Google Scholar
• Zeng J, Jing L, Hou Y, et al. Anchoring group effects of surface ligands on magnetic properties of Fe3O4 nanoparticles: towards high performance MRI contrast agents. Adv Mater. 2014;26(17):2694–2698. 2016.24615901
   PubMed Web of Science ®Google Scholar
• Johnson NJ, He S, Nguyen Huu VA, Almutairi A. Compact micellization: a strategy for ultrahigh t1 magnetic resonance contrast with gadolinium-based nanocrystals. ACS Nano. 2016;10(9):8299–8307.27588579
   PubMed Web of Science ®Google Scholar